GLSI Share Price Performance
US$11.09
-2.17 (-16.37%)
97.6% undervalued intrinsic discount
US$460.00
Fair Value
Price US$11.09
White_valkyrie US$460.00
Fair ValueUS$460.00
Share PriceUS$11.09
97.6% undervalued intrinsic discount
GLSI Community Narratives
WH
Fair Value US$460.00 97.6% undervalued intrinsic discount
Greenwich LifeSciences will eye a valued future at $460 a share, with GP2 leading the way.
5users have liked this narrative
1users have commented on this narrative
15users have followed this narrative
GLSI Community Fair Values
- US$460.00FV97.6% undervalued intrinsic discount103.00%Revenue growth p.a.5users have liked this narrative1users have commented on this narrative15users have followed this narrative5 months ago author updated this narrative
Recent GLSI News & Updates
No updates
Greenwich LifeSciences, Inc. Key Details
Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -1.24
- Gross Margin
- 0%
- Net Profit Margin
- 0%
- Debt/Equity Ratio
- 0%
Greenwich LifeSciences, Inc. Competitors
About GLSI
- Founded
- 2006
- Employees
- 6
- CEO
- WebsiteView website
Greenwich LifeSciences, Inc., a clinical-stage biopharmaceutical company, develops novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is GP2, an immunotherapy, which is in Phase III clinical trial to prevent breast cancer recurrences in patients who have previously undergone surgery. Greenwich LifeSciences, Inc. was formerly known as Norwell, Inc. and changed its name to Greenwich LifeSciences, Inc. in March 2018. The company was incorporated in 2006 and is headquartered in Stafford, Texas.
U.S. Market Performance
- 7 Days: -2.7%
- 3 Months: 11.4%
- 1 Year: 20.5%
- Year to Date: 5.9%
Over the last 7 days, the market has dropped 2.7%, driven by a pullback of 2.4% in the Information Technology sector. As for the longer term, the market has actually risen by 20% in the last year. As for the next few years, earnings are expected to grow by 15% per annum. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading